Bryan Giraudo
Net Worth

Last updated:

What is Bryan Giraudo net worth?

The estimated net worth of Mr. Bryan Giraudo is at least $4,635,104 as of 18 Jun 2024. He owns shares worth $921,619 as insider, has earned $155,065 from insider trading and has received compensation worth at least $3,558,420 in Gossamer Bio, Inc..

What is the salary of Bryan Giraudo?

Mr. Bryan Giraudo salary is $593,070 per year as Chief Operating Officer & Chief Financial Officer in Gossamer Bio, Inc..

How old is Bryan Giraudo?

Mr. Bryan Giraudo is 49 years old, born in 1976.

What stocks does Bryan Giraudo currently own?

As insider, Mr. Bryan Giraudo owns shares in one company:

Company Title Shares Price per share Total value
Gossamer Bio, Inc. (GOSS) Chief Operating Officer & Chief Financial Officer 480,010 $1.92 $921,619

What does Gossamer Bio, Inc. do?

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

GOSS logo
GOSS
Gossamer Bio, Inc.
$1.92

Bryan Giraudo insider trading

Gossamer Bio, Inc.

Mr. Bryan Giraudo has made 3 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he purchased 100,000 units of GOSS stock worth $59,100 on 18 Jun 2024.

The largest trade he's ever made was exercising 200,000 units of GOSS stock on 13 Nov 2023. As of 18 Jun 2024 he still owns at least 480,010 units of GOSS stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 100,000 $0.59 $59,100
Sale
Common Stock 6,430 $1.16 $7,433
Purchase
Common Stock 200,000 $0.56 $112,800
Purchase
Common Stock 55,000 $1.02 $56,100
Purchase
Common Stock 50,000 $0.97 $48,450
Purchase
Common Stock 13,869 $7.21 $99,995
Sale
Common Stock 10,722 $8.92 $95,587
Sale
Common Stock 5,490 $9.48 $52,045
Purchase
Common Stock 3,000 $10.01 $30,036
Purchase
Common Stock 2,000 $12.96 $25,922
Purchase
Common Stock 1,121 $16.78 $18,810
Purchase
Common Stock 1,000 $18.7 $18,700
Purchase
Common Stock 6,000 $16 $96,000

Gossamer Bio key executives

Gossamer Bio, Inc. executives and other stock owners filed with the SEC: